KLD:NYE-iShares MSCI USA ESG Select ETF (USD)

ETF | Large Blend |

Last Closing

USD 116.77

Change

+1.17 (+1.01)%

Market Cap

N/A

Volume

0.11M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Large Blend

Symbol Name Price(Change) Market Cap
VTI Vanguard Total Stock Market In..

+2.29 (+0.83%)

USD 453.93B
SPLG SPDR® Portfolio S&P 500 ETF

+0.50 (+0.76%)

USD 56.87B
SCHX Schwab U.S. Large-Cap ETF

+0.21 (+0.95%)

USD 51.16B
DYNF BlackRock US Equity Factor Rot..

+0.30 (+0.61%)

USD 14.94B
GSLC Goldman Sachs ActiveBeta® U.S..

+0.87 (+0.79%)

USD 12.23B
SPTM SPDR® Portfolio S&P 1500 Comp..

+0.56 (+0.82%)

USD 9.53B
SPLV Invesco S&P 500® Low Volatili..

+0.73 (+1.00%)

USD 7.46B
JQUA JPMorgan U.S. Quality Factor E..

+0.62 (+1.10%)

USD 5.66B
DIVO Amplify CWP Enhanced Dividend ..

+0.28 (+0.70%)

USD 4.00B
SCHK Schwab 1000 ETF

+0.22 (+0.81%)

USD 3.90B

ETFs Containing KLD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.96% 21% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.96% 21% F 30% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike